NCHHSTP Epidemiologic and Economic Modeling Agreement (NEEMA) Meeting Agenda: July 19-21, 2022 (Virtual)

NCHHSTP Epidemiologic and Economic Modeling Agreement (NEEMA) Meeting Agenda: July 19-21, 2022 (Virtual)
Day Topic Facilitator
July 19th 10:00am-3:00pm HIV and Adolescent and School Health
10:00am-10:10am Welcome and Introductions Michelle Van Handel (OD)
10:05am-10:10am Overview of division priorities and reflections Demetre Daskalakis (DHP)
10:10am-11:40am
  1. 10:10am-11:40am 1. Evaluation of testing and linkage interventions targeted to network partners of men who have sex with men (MSM)
    • Presenter: Samuel Jenness, Emory University/CAMP
  2. Impact of social distancing and stay at home orders on risk behaviors, provision and receipt of prevention/care services, and HIV transmission
    • Presenter: Steven Goodreau, University of Washington/CAMP
  3. Impact of racial and ethnic disparities on achievement of ending the HIV epidemic (EHE) goals
    • Presenter: Deven Hamilton, University of Washington/CAMP
  4. Estimation of pre-exposure prophylaxis (PrEP) need among demographic strata in the US adults and adolescents
    • Presenter: Minttu Rönn, Stanford University/PPML
11:40am-12:00pm Follow-on discussion and wrap-up for HIV (Closed meeting with NEEMA collaborators)
12:00pm-1:00pm BREAK
1:00pm-1:05pm Welcome and Introductions Taiwo Abimbola (OD)
1:05pm-1:10pm Overview of division priorities and reflections
1:10pm-2:40pm
  1. County-level estimates of sexually active adolescents
    • Presenter: Deepa Jahagirdar, Stanford University /PPML
  2. Impact of Racial and Ethnic Disparities on Achievement of ending the HIV epidemic (EHE) goals (adolescents)
    • Presenter: Deven Hamilton, University of Washington/CAMP
  3. Health and economic impact of 10-year sexual risk behavior change among U.S. high school students: pregnancies
    • Presenter: Steven Goodreau, University of Washington/CAMP
2:40pm-3:00pm Follow-on discussion and wrap-up for Adolescent and School Health (Closed meeting with NEEMA collaborators)
July 20th 11:30am-1:00pm Multi-division*
11:30am-11:35am Welcome and Introductions / Overview
11:35am-12:05pm
  1. Optimizing routine screening for HIV, viral hepatitis, STIs, and TB in clinical settings
    • Presenter: Lucia Cillioni, Johns Hopkins University/CAMP
12:05pm-12:45pm
  1. Quantifying health and economic gains from attaining health equity targets in viral hepatitis, TB and STIs
    • Presenters: Joshua Salomon, Minttu Rönn, and Yunfei Li Stanford
12:45pm-12:50pm Wrap-up and reflections
12:50pm-1:00pm BREAK
July 20th
1:00pm-3:00pm
TB
1:00pm-1:05pm Welcome and Introductions
1:05pm-1:10pm Overview of division priorities
  1. Model-based analysis of tuberculosis genotype clusters in the United States and across California, Florida, New York, and Texas; Modeling predictors of growth in large outbreaks
    • Presenter: Sourya Shrestha and Lucia Cillioni, Johns Hopkins University/CAMP
  1. Racial/ethnic disparities in TB disease outcomes in the United States
    • Presenter: Mathilda Regan (Stanford/PPML)
  2. Trends, mechanisms, and racial/ethnic differences of tuberculosis incidence in the US-born population aged 50 years or older in the United States
    • Presenter: Sun Kim/Nick Menzies, Harvard University/PPML
  3. Exploring the potential impact of the COVID-19 pandemic on future TB in the United States
    • Presenter: Nicole Swartwood, Harvard University/PPML
2:50pm-3:00pm Wrap-up and Director’s reflections
July 21st
10:00am-4:00pm
STD and Viral Hepatitis
10:00am-10:05am Welcome and Introductions Taiwo Abimbola (OD)
10:05am-10:10am Overview of division priorities and reflections Tom Gift (DSTDP)
10:10am-11:40am
  1. Engaging internal and external stakeholders in the design, development, and dissemination of STD modeling tools
    • Presenter: Erika Martin, University at Albany SUNY/CAMP
  2. Estimating the Cost-Effectiveness and HIV Impact of Screening men who have sex with men (MSM) for Chlamydia and Gonorrhea
    • Presenter: Jeb Jones, Emory
  3. University/CAMP 3. Modeling diagnostics and decision rules for addressing antimicrobial resistant gonococcal infection
    • Presenter: Reza Yaesoubi and Xuecheng Yin, Yale University/PPML
  4. Estimating the cost-effectiveness of chlamydia screening in women and men who have sex with women (MSW)
    • Presenter: Minttu Rönn, Stanford University/PPML
11:40am-12:00pm Follow-on discussion and wrap-up for STD (Closed meeting with NEEMA collaborators
12:00pm-2:00pm BREAK
2:00pm-2:05pm Welcome and Introductions Taiwo Abimbola (OD)
2:05pm-2:10pm Overview of division priorities and reflections
2:10pm-3:40pm
  1. Hepatitis B cascade of care: current status and cost-effectiveness of improvements
    • Presenter: David Hutton, University of Michigan/PPML
  2. Expanding hepatitis C screening among persons who inject drugs (PWID) towards hepatitis C elimination
    • Presenter: Lin Zhu, Stanford University/PPML
  3. Evaluating effectiveness and cost-effectiveness of different timing and testing approaches for infants perinatally exposed to hepatitis C virus
    • Presenter: Eric Hall, Oregon Health and Sciences University/CAMP
  4. Estimated number of people who inject drugs (PWID) in the United States
    • Presenter: Heather Bradley, Georgia State University/CAMP
3:40pm-4:00pm Follow-on discussion and wrap-up for Viral Hepatitis (Closed meeting with NEEMA collaborators)

*multi-division: modeling activity involving multiple diseases/topics and representing all NCHHSTP divisions.

Get Tested - Find a Testing Site Near You
Atlas Plus - Explore Interactive CDC Data
CDC 24/7 - Protecting America's Safety, Health, and Security